CARGO Therapeutics, Inc. Common Stock
NASDAQ Global SelectTotal Valuation
CARGO Therapeutics, Inc. Common Stock carries a market capitalization of 216.19M, placing it among publicly traded companies globally. Its enterprise value stands at -54.71M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 216.19M |
| Enterprise Value | -54.71M |
Share Statistics
CARGO Therapeutics, Inc. Common Stock currently has 46.50M shares outstanding.
| Shares Outstanding | 46.50M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -0.44 |
| P/TBV Ratio | 0.83 |
| P/FCF Ratio | -1.06 |
| P/OCF Ratio | -1.04 |
Financial Position
CARGO Therapeutics, Inc. Common Stock maintains a current ratio of 12.37, meaning it holds 12.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 12.37 |
| Quick Ratio | 12.12 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | 0.00 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -59.25 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
CARGO Therapeutics, Inc. Common Stock's stock has declined approximately -81.52893% over the past 52 weeks. The 50-day moving average sits at 4.45, while the 200-day moving average is 7.81.
| Beta (5Y) | N/A |
| 52-Week Price Change | -81.52893% |
| 50-Day Moving Average | 4.45 |
| 200-Day Moving Average | 7.81 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -150.25M, while operating income came in at -155.19M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -155.19M |
| Pretax Income | -221.78M |
| Net Income | -221.78M |
| EBITDA | -150.25M |
| EBIT | -155.19M |
| Earnings Per Share (EPS) | -4.63 |
Balance Sheet
CARGO Therapeutics, Inc. Common Stock holds 252.57M in cash and equivalents against 578,000.00 in total debt, resulting in a net debt position of -107.75M. Total book value stands at -447.04M, with working capital of 237.70M providing operational flexibility.
| Cash & Cash Equivalents | 252.57M |
| Total Debt | 578,000.00 |
| Net Debt | -107.75M |
| Equity (Book Value) | -447.04M |
| Book Value Per Share | -9.34 |
| Working Capital | 237.70M |
Cash Flow
CARGO Therapeutics, Inc. Common Stock produced -189.59M in operating cash flow over the past twelve months. After subtracting -3.48M in capital expenditures, free cash flow totaled -193.07M - equivalent to -4.03 per share.
| Operating Cash Flow | -189.59M |
| Capital Expenditures | -3.48M |
| Free Cash Flow | -193.07M |
| FCF Per Share | -4.03 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -0.14 |
| FCF Yield | -94.34 |
Scores
CARGO Therapeutics, Inc. Common Stock posts an Altman Z-Score of 2.36, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.36 |